Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-09-04 Purchase | 2024-09-04 5:42 pm | Dyne Therapeutics Inc. | DYN | Cox John CEO & President | 32,000 | $33.04 | $1,057,216 | 13,000 (Indirect Direct) | View |
2020-03-24 Sale | 2020-03-26 7:31 pm | REPLIGEN CORP | RGEN | Cox John Director | 1,858 | $96.72 | $179,706 | 923 (Direct) | View |
2020-03-18 Sale | 2020-03-20 4:25 pm | REPLIGEN CORP | RGEN | Cox John Director | 26,736 | $95.27 | $2,547,035 | 2,781 (Direct) | View |
2020-03-04 Sale | 2020-03-05 5:52 pm | REPLIGEN CORP | RGEN | Cox John Director | 10,000 | $93.39 | $933,900 | 16,781 (Direct) | View |
2020-02-24 Sale | 2020-02-26 4:27 pm | REPLIGEN CORP | RGEN | Cox John Director | 4,455 | $92.81 | $413,455 | 2,781 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership(A) | 2024-04-04 9:07 pm | N/A N/A | Dyne Therapeutics Inc. | DYN | Cox John CEO & President | 0 | $0 | 5,000 (Direct) | View |
2024-03-25 Option Award | 2024-03-27 4:24 pm | N/A 2034-03-24 | Dyne Therapeutics Inc. | DYN | Cox John See Remarks | 679,853 | $0 | 679,853 (Direct) | View |
Ownership | 2024-03-27 4:13 pm | N/A N/A | Dyne Therapeutics Inc. | DYN | Cox John See Remarks | 0 | $0 | 10,000 (Direct) | View |
2023-08-11 Disposition | 2023-08-11 4:10 pm | N/A 2033-05-18 | Sigilon Therapeutics Inc. | SGTX | Cox John Director | 683 | $6.6439 | 0 (Direct) | View |
2023-08-11 Disposition | 2023-08-11 4:10 pm | N/A N/A | Sigilon Therapeutics Inc. | SGTX | Cox John Director | 341 | $0 | 0 (Direct) | View |
2023-08-11 Disposition | 2023-08-11 4:10 pm | N/A 2032-05-25 | Sigilon Therapeutics Inc. | SGTX | Cox John Director | 683 | $4.9984 | 0 (Direct) | View |
2023-05-19 Option Award | 2023-05-22 4:20 pm | N/A 2033-05-18 | Sigilon Therapeutics Inc. | SGTX | Cox John Director | 8,888 | $0 | 8,888 (Direct) | View |
2022-05-26 Option Award | 2022-05-27 5:00 pm | N/A 2032-05-25 | Sigilon Therapeutics Inc. | SGTX | Cox John Director | 8,888 | $0 | 8,888 (Direct) | View |
2021-06-24 Option Award | 2021-06-28 07:15 am | N/A 2031-06-23 | Sigilon Therapeutics Inc. | SGTX | Cox John Director | 8,888 | $9.97 | 8,888 (Direct) | View |
2020-12-08 Conversion | 2020-12-10 6:15 pm | N/A N/A | Sigilon Therapeutics Inc. | SGTX | Cox John Director | 4,444 | $0 | 4,444 (Indirect) | View |
Ownership | 2020-12-03 8:42 pm | N/A N/A | Sigilon Therapeutics Inc. | SGTX | Cox John Director | 0 | $0 | 59,999 (Indirect) | View |
2020-03-18 Exercise | 2020-03-20 4:25 pm | N/A N/A | REPLIGEN CORP | RGEN | Cox John Director | 2,434 | $38.76 | 2,781 (Direct) | View |
2020-03-18 Exercise | 2020-03-20 4:25 pm | N/A N/A | REPLIGEN CORP | RGEN | Cox John Director | 3,366 | $26.12 | 2,781 (Direct) | View |
2020-03-18 Exercise | 2020-03-20 4:25 pm | N/A N/A | REPLIGEN CORP | RGEN | Cox John Director | 3,632 | $41.19 | 2,781 (Direct) | View |
2020-03-18 Exercise | 2020-03-20 4:25 pm | N/A N/A | REPLIGEN CORP | RGEN | Cox John Director | 14,000 | $12.91 | 2,781 (Direct) | View |
2020-03-18 Exercise | 2020-03-20 4:25 pm | N/A N/A | REPLIGEN CORP | RGEN | Cox John Director | 3,304 | $42.07 | 2,781 (Direct) | View |
2020-03-18 Exercise | 2020-03-20 4:25 pm | N/A 2023-11-15 | REPLIGEN CORP | RGEN | Cox John Director | 26,736 | $0 | 2,781 (Direct) | View |
2020-03-04 Exercise | 2020-03-05 5:52 pm | N/A N/A | REPLIGEN CORP | RGEN | Cox John Director | 10,000 | $12.91 | 16,781 (Direct) | View |
2020-03-04 Exercise | 2020-03-05 5:52 pm | N/A 2023-11-15 | REPLIGEN CORP | RGEN | Cox John Director | 10,000 | $0 | 16,781 (Direct) | View |